homesmall email search  
 
     
home management science partners contact
 
lineVideo - demo.
Get Flash to see this player.
line
Journal on focus
Cell Cycle
Editor-in-Chief
M.V. Blagosklonny
, M.D., Ph.D.
Ordway Research Institute
Cancer Center
Albany, NY
line
Gallery
line
 
  Anti-aging today.
 
   
 
Our mission is a novel use of existing drugs as patentable drug formulations and drug combinations. The goal is to minimize costs of drug development, to maximize success rate, to accelerate clinical applications, and to rapidly satisfy unmet medical needs in age-related diseases and cancer.

read more
 
FOCUS
   
Anti-aging drug today
Therapy of age-related diseases by slowing aging based on novel
use of rapamycin, its combinations and formulations.
Toxicity-free cancer therapy
therapy of cancer without side effects by drug combinations that selectively kill cancer cells, while sparing normal cells, based on drug resistance and cell cycle.

LATEST NEWS
 
Feb. 29, 2008 - Announcement: Oncotarget Inc. is looking for collaborations in the area of anti-cancer drugs with defined targets.
Sept. 1, 2007 - On September 1, 2007 Oncotarget Inc. was awarded Phase I of STTR - NIH grant "Drug discovery for diabetic retinopathy."

 

 
 
HOME | MANAGEMENT | SCIENCE | PARTNERS | CONTACT
Copyright 2008 © ONCOTARGET Inc. Albany, NY 12203